OncoTargets and Therapy · 2017 · 14 citations · 27 references
MedicineCancer BiologyOncologyGene ExpressionMetastasisMolecular OncologyCancer ProgressionMalignant NeoplasmsMetastatic Urologic CancerMicrorna BiologyMicrorna-mediated RegulationRenal Cell CarcinomaCancer Metastasis MechanismsMicrorna Function In CancerMicrorna In CancerMicrorna In Cell ProliferationMicrorna Regulation In CancerQuantitative Polymerase Chain ReactionReal-time Polymerase Chain Reaction (Pcr)Real-time Polymerase Chain Reaction Assays
The clear cell renal cell carcinoma (ccRCC) is one of the most fatal urologic tumors, and the prognosis remains very poor for advanced or metastatic ccRCC. This study reveals the roles of microRNA (miR)-30c in regulating a highly aggressive ccRCC cell line proliferation by targeting MTA-1, which is a key mediator for human cancer metastasis. Results from quantitative real-time polymerase chain reaction showed that the expression of MTA-1, the target of miR-30c, was significantly higher in metastatic ccRCC specimens than in nonmetastatic ccRCC or nontumor specimens. Accordingly, endogenous miR-30c is at a much lower level in highly aggressive ccRCC Caki-1 cells than nontumor or ccRCC cell lines. Expression of miR-30c via lentivirus vector inhibits the proliferation, anchorage-independent growth, in vitro invasion or migration, or in vivo growth of Caki-1 cells by repressing MTA-1 protein expression. miR-30c also enhances the sensitivity of Caki-1 cells to anticancer agents, including sorafenib and paclitaxel. These data reveal the potential application of miR-30c and that its targeting gene, MTA-1, would be a potential target in metastatic ccRCC treatment.
27
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
Bernard Escudier, Tim Eisen, Walter M. Stadler et al. · New England Journal of Medicine · 2007 · 4.8K citations · Full text
Medicine, Nephrology, Oncology +11
Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma
Lijun Zhou, Mingli Sun, Xian Zhang et al. · Oncogene · 2015 · 393 citations
Medicine, Oncology, Pharmacology +12